.Merck beats profits expectations, raises sales outlook on sturdy demand for top drugs like Keytruda CNBCMerck & Co. (MRK US) Defeats Earnings Estimates as Keytruda Purchases Rise BloombergMerck Stock: Pharma Giant Posts Strong Results, Yet Expectation Tumbles Short Financier's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats income as well as purchases desires amid Keytruda strong point, yet gives mixed full-year outlook MarketWatch.